Continuous Glucose Monitors & GMI: Is this TMI?
Manage episode 319955350 series 2908322
Katelyn (Kate) R. Neverman, Pharm.D., identifies three continuous glucose monitors (CGMs) approved by the FDA, describes the difference between glucose management indicator (GMI) and hemoglobin A1c and discusses how to interpret glycemic data using an Ambulatory Glycemic Profile (AGP) report.
For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter!
You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
101 episodi